UK: So Nobody Wants Your Life Sciences App?

Last Updated: 6 November 2017
Article by David Rosner

Computer and smart phone applications are pervasive across the world and cover almost every conceivable facet of a peoples lifestyle choices. As of March 2017, the two largest app stores had a collective library of apps totalling 5 billion.1 However, as demonstrated by our report, ' Pharma and the connected patient: How digital technology is enabling patient centricity', the uptake of applications produced by Life Science companies remains low. This week's blog is by David Rosner, a principle in the firm's US practice, and it was recently featured on the US Centre for Health Solutions site.2 David references our report and explores some of the reasons for the low uptake of applications by Life Sciences companies.

Don't be surprised. Instead, take a brutally honest look at what it's offering.

With the UK Centre for Health solutions having recently completed a significant piece of research,3 we can now say officially what you surely already know: there's a good chance patients have no interest in your app, whether it's the one you launched just last year or even the one you're planning for next year. Although many pharma companies are churning out new apps at a healthy clip, adoption and usage rates for many such apps are stagnant and show no signs of increasing any time soon.

In some industries, this would lead to a simple conclusion: "Let's just stop investing in consumer-facing apps." But for leaders at pharmaceutical companies, this can be a difficult conclusion to reach, for a number of reasons. Chief among them is the fact that patient-centricity is a very real and important strategic goal. Set aside the issue of whether or not to invest in an app for a moment. Regardless of that decision, becoming patient-centric remains a strategic pillar for many in the industry. Now, consider the limited options many pharmaceutical companies have for making direct connections with their customers. In that light, even the glimmer of potential to connect with customers through a new avenue – in this case, mobile apps – may make the pursuit of a successful app worth the effort.

Apps in the world of pharmaceuticals can succeed. But it can take a razor-sharp approach, a little creativity, and perhaps more than anything, brutal self-directed honesty, in order to make the investment in an app worth it. Why honesty? Because many of the companies that launch successful apps in this space start with a crystal-clear understanding of their place in their customers' worlds, which often means recognizing that their place can, in fact, be very small – and working out from there.

Here are some critical self-assessment questions that any pharmaceutical company should answer before starting down the path of an app, or when trying to create new relevance for one that's already been launched.

Are we really able to promise anything of utility or value?

We know from customer experience research that while companies tend to overestimate the value of their products – in this case, an app – to customers, the customers themselves tend to undervalue them. For the companies offering the product, it can take a lot of work to overcome this gap in perceptions. For pharmaceutical companies, this can be made even more difficult by the fact that the manufacturer is only one of several key players in patient treatment. Those that are able to bridge the gap are able to do so usually because they address an unmet patient need – or help caregivers meet those needs. Which needs, exactly? Having a positive impact on patient outcomes is an obvious target, but there are others. For example, simply making a patient's life easier during the complex onboarding process (reimbursement, education, etc.) for a specialty product could be of great value, even if it doesn't have a direct link to outcomes.

What's the lifespan of this app?

Many mobile apps tend to be short-lived or disposable – use once, then delete. For pharmaceutical companies, it can help to consider the app in the context of the overall patient journey before beginning development. Maybe, for example, the patient is expected to use the app only a few times, given the length of treatment. In that case, requiring a username and password could be a huge barrier to adoption. In some cases, based on the arc and timing of treatment, an app may not even be the right answer – email, SMS text messaging, or other interventions may provide the equivalent level of value without the need for registration.

Do we have the brand permission among our customers to make this a success? If not, who does – and can we partner with them?

We recently conducted research showing that among those offering health apps, those from pharmaceutical companies and medical device manufacturers were trusted least by consumers. Meanwhile, those developed by patient groups and doctors enjoyed the highest level of trust. For pharma leaders considering bringing a new app to market, this begs the question of whether or not they have the brand permission required to be successful. If the answer is "no," don't despair. A number of pharma companies have partnered with others in the patient care ecosystem who do have brand permission to deliver successful apps. Roche's "mySugr" and Pfizer's "Quitter's Circle" are both examples of successful apps cosponsored by patient groups that are well known within their individual therapeutic areas.

Does an app sound like more trouble than it's worth after reading this? It may be. But it doesn't have to be, either – not when you consider the potential results in terms of patient engagement and becoming more patient-centric. The key is to avoid starting down the path toward an app simply because there is mounting pressure to do so. On the other hand, if the business case is clear, develop a firm understanding of the value your app can really offer, as well as the value customers and patients are actually seeking, and from whom they're seeking it. Once you connect the dots on those critical elements, your chances of success may take a quantum leap forward.





The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions